🇺🇸 MRK — Merck & Co., Inc.

Salud Compra
← Volver

Precio actual

146,73 USD

Máx. histórico

156,45

73 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-6,21%

Rango 52 semanas

85,24 – 156,92

Variación hoy

-0,14%

Cierre anterior

146,94

Rango de hoy

142,80 – 147,48

Volumen hoy

7.462.267

Peor caída histórica

-68,62%

28/12/2000 → 09/03/2009

Recuperado en 1796 días

Volatilidad anualizada ⓘ

25,43%

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
148,21 (puede no estar actualizado)
Dividend yield
2,31% (puede no estar actualizado)
Precio objetivo analistas
161,53 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 19 horas
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,4000 USD · Yield: 2,32%
Fecha de pago Importe por participación
15/09/2026 0,8500 USD
15/06/2026 0,8500 USD
16/03/2026 0,8500 USD
15/12/2025 0,8500 USD
15/09/2025 0,8100 USD
16/06/2025 0,8100 USD
17/03/2025 0,8100 USD
16/12/2024 0,8100 USD
16/09/2024 0,7700 USD
17/06/2024 0,7700 USD
14/03/2024 0,7700 USD
14/12/2023 0,7700 USD
14/09/2023 0,7300 USD
14/06/2023 0,7300 USD
14/03/2023 0,7300 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
22/09/2008 30,52 31,13 29,91 30,01 -1,23% 3,97% 12.337.894
19/09/2008 31,15 31,36 29,12 30,38 -0,28% 7,20% 26.693.294
18/09/2008 29,99 30,57 29,23 30,47 +2,57% 4,49% 20.807.202
17/09/2008 30,31 30,73 29,57 29,70 -3,56% 3,81% 23.541.853
16/09/2008 30,79 31,28 30,07 30,80 -1,34% 3,94% 22.961.994
15/09/2008 31,59 32,30 31,21 31,22 -3,25% 3,44% 16.216.123
12/09/2008 32,26 32,68 32,00 32,27 -0,50% 2,10% 11.515.005
11/09/2008 31,60 32,54 31,60 32,43 +1,40% 2,96% 17.416.607
10/09/2008 32,85 32,91 31,75 31,98 -2,39% 3,54% 18.333.083
09/09/2008 33,87 34,21 32,74 32,77 -3,21% 4,34% 15.416.290
08/09/2008 33,36 33,89 32,94 33,86 +3,44% 2,86% 17.110.277
05/09/2008 32,31 32,80 32,05 32,73 +0,38% 2,30% 16.092.774
04/09/2008 32,88 33,23 32,52 32,61 -1,44% 2,18% 14.468.374
03/09/2008 33,21 33,27 32,50 33,08 -0,46% 2,33% 9.457.781
02/09/2008 33,99 34,43 32,84 33,23 -2,36% 4,66% 18.179.132
29/08/2008 34,65 34,67 33,88 34,04 -2,01% 2,26% 12.124.417
28/08/2008 34,27 34,90 34,25 34,73 +1,88% 1,89% 9.808.546
27/08/2008 33,80 34,23 33,41 34,09 +0,88% 2,43% 8.385.258
26/08/2008 33,38 34,23 33,25 33,80 +1,20% 2,92% 13.519.410
25/08/2008 33,56 33,70 32,98 33,40 -0,77% 2,16% 11.772.708
22/08/2008 33,40 33,88 33,16 33,65 +1,29% 2,17% 10.114.038
21/08/2008 33,26 33,39 32,59 33,23 -0,34% 2,41% 14.778.582
20/08/2008 33,64 33,81 33,11 33,34 -0,88% 2,07% 10.150.614
19/08/2008 33,85 34,06 33,40 33,64 -1,29% 1,95% 10.759.921
18/08/2008 34,64 34,83 33,87 34,07 -1,24% 2,75% 8.298.064
15/08/2008 34,41 34,97 34,41 34,50 +0,61% 1,64% 9.323.532
14/08/2008 33,99 34,59 33,65 34,29 +0,56% 2,78% 11.555.877
13/08/2008 34,26 35,05 34,06 34,10 -1,19% 2,90% 12.596.122
12/08/2008 33,97 34,68 33,97 34,51 +0,72% 2,08% 12.185.620
11/08/2008 34,20 34,30 33,99 34,27 -0,11% 0,92% 13.773.864